Tag: FDA policy

Future Role of Authorized Generics: Market Outlook

Authorized generics are brand-name drugs sold under a generic label. As patent cliffs hit in 2025-2030, their role is shifting from market control to managed transition - driven by FDA policy, U.S. manufacturing incentives, and growing pressure for affordable drugs.